WhiteOak Capital Pharma and Healthcare Fund
NAV
₹17.3
as of 6 Oct 2026
WhiteOak Capital Pharma and Healthcare Fund is an open-ended Sectoral/ Thematic scheme from WhiteOak Capital Mutual Fund managing ₹825 crore (as of 31 Jul 2026). Its Direct-plan NAV is ₹17.3 as of 6 Oct 2026. The expense ratio is 1.13% a year. Managed by Piyush Baranwal. This page is factual data only – it carries no rating and no recommendation.
Key facts
- Expense ratio
- 1.13% / yr
- as of 31 Aug 2026
- Fund size
- ₹825 crore
- as of 31 Jul 2026
- Exit load
- None
- SIP available
- Yes
- Launched
- 6 Feb 2024
- ISIN
- INF03VN01886
₹100 invested, fund vs category
The category line is the average of the funds in this category, built from nyvo’s own NAV data.
Rebased to 100data to 5 Oct 2026Benchmark: Nifty 500 Healthcare TRI
WhiteOak Capital Pharma and Healthcare Fund
₹171
+71% on ₹100 over 2.7 yrs
Sectoral/ Thematic average
₹144
+44% on ₹100 over 2.7 yrs
Returns vs category
| Window | Fund | Category avg | Gap |
|---|---|---|---|
| 3 months | 2.26% | – | – |
| 6 months | 21.91% | – | – |
| 1 year | 20.07% | – | – |
No category average is available for this fund. Short windows are noise; the 3 and 5-year rows are the record. Past returns do not predict future returns.
A single return number depends on its start date. These are ALL the overlapping holding periods, so the worst case is visible – read that number first.
1-year holding periods
- Worst
- 1.4%
- Median
- 19.5%
- Best
- 31.6%
21 windows over the last 32 months, stepped monthly; 100% ended positive. Worst window began 1 Jan 2025. Windows overlap – this is the range of past start dates, not a probability of anything.
Distance below its own peak
Every dip below 0 is the fund trading under a previous high – how deep and for how long is what a drawdown feels like.
Right now
-5.0% below peak
Where the money actually is
Equity
99.2%
Cash
0.8%
Whole-portfolio split, as of 31 Jul 2026.
What it owns
65 positions · top 10 = 46.4%
Market-cap mix
Large 31.0%Mid 23.0%Small 41.8%Other 4.3%
as of 31 Jul 2026
Holdings by sector
Healthcare(10 in top 10)88.2%
- Sun Pharmaceuticals Industries Ltd8.53%
- Torrent Pharmaceuticals Ltd7.81%
- Laurus Labs Ltd4.94%
- Apollo Hospitals Enterprise Ltd4.78%
- Divi's Laboratories Ltd3.86%
- Max Healthcare Institute Ltd Ordinary Shares3.76%
- Cipla Ltd3.72%
- Sai Life Sciences Ltd3.18%
- Zydus Lifesciences Ltd2.94%
- Neuland Laboratories Ltd2.87%
- Basic Materials6.2%
Sectors marked ▶ expand to show this fund’s top-10 holdings in that sector. Holdings as of 31 Jul 2026. Portfolio turnover 321.4% a year.
Exposure figures are gross: funds that use derivatives (arbitrage, hedged books) hold offsetting positions, so concentration and turnover can read above 100%.
The businesses it owns
- P/E (trailing)
- 46.4
- P/B
- 7.4
- Dividend yield
- 0.6%
- Net margin
- 15.7%
- Earnings growth
- 16.5%
- Avg market cap
- ₹53,954 crore
Money in, money out
- Net flow, 12 months
- +₹303 cr
- Net flow, 3 months
- +₹119 cr
as of 31 Jul 2026. Flows follow performance more than they predict it.
Quick answers
- What is the NAV of WhiteOak Capital Pharma and Healthcare Fund?
- ₹17.3 per unit as of 6 Oct 2026 (Direct plan, growth). NAV is declared daily on working days.
- What is the expense ratio of WhiteOak Capital Pharma and Healthcare Fund?
- 1.13% a year for the Direct plan, as of 31 Aug 2026.
- How large is WhiteOak Capital Pharma and Healthcare Fund?
- ₹825 crore under management as of 31 Jul 2026, in the Sectoral/ Thematic category.
- How risky is WhiteOak Capital Pharma and Healthcare Fund?
- Its SEBI Riskometer reading is "Very High Risk". One sector, one story. The most-launched shelf on the map, by far.
- Who manages WhiteOak Capital Pharma and Healthcare Fund?
- Piyush Baranwal, managing this fund for 2.6 years.
Where this fund sits
Its shelf, all funds
St · Sectoral / thematic →
One sector, one story. The most-launched shelf on the map, by far.
The money map
How big this shelf is in India →
The whole industry sized by real money, from AMFI’s monthly data.
Side by side
Compare this fund →
Put it next to any other fund – growth, returns, risk and cost in one table.
One bet or two?
Check its overlap →
See whether it owns the same stocks as your other funds.
Other Sectoral/ Thematic funds
- ICICI Prudential India Opportunities Fund₹38,338 crore
- ICICI Prudential Business Cycle Fund₹15,873 crore
- WhiteOak Capital Special Opportunities Fund₹1,801 crore
- UTI Innovation Fund₹837 crore
- Axis Quant Fund₹827 crore
- ICICI Prudential Conglomerate Fund₹817 crore
- Edelweiss Technology Fund₹810 crore
- WhiteOak Capital Banking & Financial Services Fund₹653 crore
Data: nyvo research systems; each block above states its own as-of date, and blocks with no data for this fund are omitted rather than estimated. NAV updates daily on working days. The benchmark (Nifty 500 Healthcare TRI) is named for reference only; its values are licensed and never shown. This page is factual information about one scheme. It is not investment advice, not a recommendation, and it carries no rating of any kind. Past performance does not predict future returns. Mutual fund investments are subject to market risks; read all scheme related documents carefully.